EX20
🇦🇺 ASX
👑 Overview
📈 Performance
📙 Holdings
💰 Distributions
💵 Cost
🍃 Esg
🤓 Advanced
👨👩👧👦 Community
📈
N/A
Annual Growth
5 years average annual capital growth
💰
3.31%
Annual distribution yield
Based on the most recent distribution
💵
$ 500
Minimum Order
Due to regulatory requirements
🌏
16
Pearlers Invested
Since January 2020
👑 Overview
Key information
🔎 Fund Overview
EX20.AX was created on 2016-10-05 by BetaShares. The fund's investment portfolio concentrates primarily on large cap equity. The ETF currently has 234.2m in AUM and 180 holdings. EX20.AX aims to track the performance of an index (before fees and expenses) comprising the 180 largest stocks listed on the ASX, after excluding the 20 largest, based on their market capitalisation.
📈 Performance
Price History
+34.42%
1M
All Time
Graph
Table
Unsure how much or often to invest?
🗓️ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out →💵 Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out →⏱️ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out →📙 Top Holdings
Show more
Updated as of 25 May 2023
Industry Exposure
🧱 Materials
23%
🏭 Industrials
13%
🏡 Real Estate
12%
🏦 Financials
12%
📙 Other
8%
🩺 Health
8%
🛍️ Consumer
7%
🤖 Information
6%
🔋 Energy
4%
📞 Communication
4%
⚡️ Utilities
4%
Country Exposure
🇦🇺 Australia
93%
🇳🇿 New Zealand
3%
🇮🇪 Ireland
2%
🇲🇾 Malaysia
1%
💰 Distributions
Payouts
💰 Annual Distribution Yield*
3.31%
💰 Annual Distribution Earnings Per $1,000 invested**
$33.13
💰 Most Recent Distribution Franked Percentage Estimate
63.20%
💰 Average Distribution Franked Percentage Estimate
55.64 %
💰 Distribution reinvestment
* Based on the most recent distribution
** Calculated by multiplying the most recent distribution yield by $1,000
Distribution History
1Y
5Y
10Y
Graph
Table
Year
Yearly Distribution Earnings Per Share
Franking Estimate
2025
$0.00
0.00%
2024
$0.00
0.00%
2023
$0.00
0.00%
2022
$0.53
63.20%
2021
$0.39
55.71%
2020
$0.51
60.78%
2019
$0.87
55.42%
2018
$0.78
54.39%
2017
$0.27
25.40%
2016
$0.00
0.00%
💵 Costs
💼
0.25%
Management Fee
Included in unit price, not charged by Pearler
💸
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator🤓 Advanced information
Technical Info
💰 Price*
$19.84
💰 Price To Earnings Ratio
12.46
💰 Price To Book Ratio
1.77
💰 Leveraged
No
💰 Inverse
No
*Price may be up to 24 hours old
👩👩👦 Community Insights
How our community is investing
🌏 Pearlers invested in EX20
16
📊 Total Capital Earnings
N/A
🔃 Average investment frequency
N/A
💵 Average investment amount
N/A
⏰ Last time a customer invested in EX20
681 days
EX20 investor breakdown
💵 Income of investors
More than 200k
150k - 200k
16%
100k - 150k
8%
50k - 100k
44%
Less than 50k
24%
👶 Age of investors
18 - 25
13%
26 - 34
19%
35 - 90
69%
🙋 Legal gender of investors
Female
44%
Male
56%
Pearlers who invest in EX20 also invest in...
VAS.AX was created on 2009-05-04 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard Australian Shares Index ETF seeks to track the return of the S&P/ASX 300 Index before taking into account fees, expenses and tax.
📊 Share price
$90.18 AUD
NULL AUSTRALIA
NULL BETA
VDHG.AX was created on 2017-11-20 by Vanguard. The fund's investment portfolio concentrates primarily on target outcome asset allocation. Vanguard Diversified High Growth Index ETF seeks to track the weighted average return of the various indices of the underlying funds in which it invests, in proportion to the Strategic Asset Allocation, before taking into account fees, expenses and tax.
📊 Share price
$57.36 AUD
NULL GLOBAL
NULL SMART BETA
A200.AX was created on 2018-05-07 by BetaShares. The fund's investment portfolio concentrates primarily on large cap equity. The ETF currently has 2975.21m in AUM and 200 holdings. A200.AX aims to track the performance of an index (before fees and expenses) comprising 200 of the largest companies by market capitalisation listed on the ASX.
📊 Share price
$120.79 AUD
NULL AUSTRALIA
NULL BETA
IVV.AX was created on 2000-05-15 by iShares. The fund's investment portfolio concentrates primarily on large cap equity. The Fund aims to provide investors with the performance of an index, before fees and expenses. The index is designed to measure the performance of large capitalisation US equities.
📊 Share price
$43.11 AUD
NULL US
NULL EX AUSTRALIA
NULL BETA
VTS.AX was created on 2009-05-12 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard U.S. Total Market Shares Index ETF seeks to track the performance of the CRSP US Total Market Index, providing investors with exposure to a broadly diversified collection of securities that, in the aggregate, approximates the full index in terms of key characteristics.
📊 Share price
$320.13 AUD
NULL US
NULL EX AUSTRALIA
NULL BETA
Want more shares? Try these...
EX1N
Exopharm Ltd. engages in the development and commercialization of exosomes as therapeutic agents. The company is headquartered in Melbourne, Victoria. The company went IPO on 2018-12-18. The firm's principal activities include pipeline products analysis and selection; technology development and validation; and commercial collaborations. The firm operates through regenerative medicine and biopharmaceutical drug development segment. Its exosome technologies solve the needs for the success of exosome medicines. Its technologies include LEAP manufacturing technology, LOAD active pharmaceutical ingredients (APIs) loading technologies, and EVPS tropism technologies. The firm is developing Engineered EVs (EEVs), an emerging form of precision medicine with application in areas, such as neurology, cardiology, and oncology. Its EEV technology includes EVPS to provide tissue tropism to exosomes and LOAD to load in APIs, such as messenger ribonucleic acid (mRNA).